Quick Answer
Baird Medical Investment Holdings Ltd reported R&D Expense of $6.17 million for fiscal year 2024.
Baird Medical Investment Holdings Ltd R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $6.17M | +44.4% |
| 2023 | $4.27M | +10.8% |
| 2022 | $3.86M | — |
- Baird Medical Investment Holdings Ltd showed an increase of +44.4% in R&D Expense compared to the prior fiscal year.
- Over the 2022–2024 period, Baird Medical Investment Holdings Ltd’s r&d expense has grown by 60.0% (from $3.86 million to $6.17 million).
- The most recent figure is from Baird Medical Investment Holdings Ltd’s fiscal year 2024 report (Form 20-F), filed with the SEC on May 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: